Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06151236
Title Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Melanoma Institute Australia
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Melanoma Institute Australia RECRUITING Wollstonecraft New South Wales 2065 Australia Details
Melanoma Institute Australia RECRUITING Wollstonecraft New South Wales 2065 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field